In vitro estrogenicity of polybrominated diphenyl ethers, hydroxylated PBDEs, and polybrominated bisphenol A compounds

Environmental Health Perspectives

Volumn 109, Issue 4, 2001, Pages 399-407

  Meerts, Ilonka A T M ^a,f   Letcher, Robert J ^b,g   Hoving, Saske ^a   Marsh, Göran ^c   Bergman, Åke ^c   Lemmen, Josephine G ^d   Van Der Burg, Bart ^d   Brouwer, Abraham ^a,e  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d HUBRECHT INSTITUTE   (Netherlands)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

^f Notox BV   (Netherlands)

^g UNIVERSITY OF WINDSOR   (Canada)

Author keywords

ER CALUX; Estrogenicity; Flame retardants; Hydroxylated compounds; Polybrominated diphenyl ethers

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; ESTROGEN RECEPTOR; ETHER DERIVATIVE; LUCIFERASE; POLYBROMINATED BIPHENYL; RECEPTOR SUBUNIT;

AGONIST; ARTICLE; ASSAY; BREAST CANCER; BROMINATION; CELL LINE; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO CELL; ESTROGEN ACTIVITY; GENE CONSTRUCT; GENE EXPRESSION; GENE INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CELL; METABOLISM; PRIORITY JOURNAL; REPORTER GENE;

EID: 0035025255     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.01109399     Document Type: Article

References (57)

1. WHO. Brominated Diphenyl Ethers. Environ Health Criteria 162. Geneva:World Health Organization, 1994.
2. De Boer J, de Boer K, Boon JP. Polybrominated biphenyl and diphenyl ethers. In: The Handbook of Environmental Chemistry, Vol 3, Part K: New Types of Persistent Halogenated Compounds (Paasivirta J, ed). Heidelberg, Germany:Springer-Verlag, 1999;61-95.
3. Pijnenburg AMCM, Everts JW, de Boer J, Boon JP. Polybrominated biphenyl and diphenyl ether flame retardants: analysis, toxicity, and environmental occurence. In: Reviews of Environmental Contamination and Toxicology, Vol 141 (Ware GW, ed). New York:Springer-Verlag, 1995;1-20.
4. De Boer J, Wester PG, Klamer HJC, Lewis WE, Boon JP. Do flame retardants threaten ocean life? Nature 394:28-29 (1998).
5. Haglund PS, Zook DR, Buser H-S, Hu J. Identification and quantification of polybrominated diphenylethers and methoxy-polybrominated diphenylethers in Baltic biota. Environ Sci Technol 31:3281-3287 (1997).
6. Jansson B, Asplund L, Olsson M. Brominated flame retardants - ubiquitous environmental pollutants? Chemosphere 16(10-12):2343-2349 (1987).
7. Lindström G, Wingfors H, Dam M, Van Bavel B. Identification of 19 polybrominated diphenyl ethers (PBDEs) in long-finned pilot whale (Globicephala melas) from the Atlantic. Arch Environ Contam Toxicol 36:355-363 (1999).
8. Meironyté D, Norén K, Bergman Å Analysis of polybrominated diphenyl ethers in Swedish human milk. A time-related trend study, 1972-1997. J Toxicol Environ Health 58:329-341 (1999).
9. Sj̈din A, Hagmar L, Klasson-Wehler E, Kronholm-Diab K, Jakobsson E, Bergman Å. Flame retardant exposure: polybrominated diphenyl ethers in blood from Swedish workers. Environ Health Perspect 107(suppl 8):643-648 (1999).
10. Stanley JS, Cramer PH, Thornburg KR, Remmers JC, Breen JJ, Schwemberger J. Mass spectral confirmation of chlorinated and brominated diphenyl ethers in human adipose tissues. Chemosphere 23:1185-1195 (1991).
11. Darnerud PO, Sinjari T. Effects of polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) on thyroxine and TSH blood levels in rats and mice. Organohalogen Compounds 29:316-319 (1996).
12. Fowles JR, Fairbrother A, Baecher-Steppan L, Kerkvliet NI. Immunologic and endocrine effects of the flame-retardant pentabromodiphenyl ether (DE-71) in C57BL/6J mice. Toxicology 86:49-61 (1994).
13. Meerts IATM, Van Zanden JJ, Luijks EAC, Van LeeuwenBol I, Marsh G, Jakobsson E, Bergman Å, Brouwer A. Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. Toxicol Sci 56:95-104 (2000).
14. Brucker-Davis F. Effects of environmental synthetic chemicals on thyroid function. Thyroid 8:827-856 (1998).
15. Brouwer A, Morse DC, Lans MC, Schuur AG, Murk AJ, Klasson-Wehler E, Bergman Å, Visser TJ. Interactions of persistent environmental organohalogens with the thyroid hormone system: mechanisms and possible consequences for animal and human health. J Toxicol Ind Health 14:59-84 (1998).
16. Hanberg A, Ståhlberg M, Georgellis A, De Wit C, Ahlborg U. Swedish dioxin survey: evaluation of the H-4IIE bioassay for screening environmental samples for dioxin-like enzyme induction. Pharmacol Toxicol 69:442-449 (1991).
17. Von Meyerinck L, Hufnagel B, Schmoldt A, Benthe HF. Induction of rat liver microsomal cytochrome P-450 by the pentabromodiphenyl ether Bromkal 70 and half-lives of its components in the adipose tissue. Toxicology 61:259-274 (1990).
18. Aarts JMMJG, Denison MS, Cox MA, Schalk AC, Garrison PA, Tullis K. de Haan LHJ, Brouwer A. Species-specific antagonism of Ah receptor action by 2,2′,5,5′-tetrachloro-and 2,2′,3,3′,4,4′-hexachlorobiphenyl. Eur J Pharmacol Environ Toxicol 293:463-474 (1395).
19. Garrison PM, Tullis K, Aarts JMMJG, Brouwer A, Giesy J. Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachloro-dibenzo-p-dioxin-like chemicals. Fundam Appl Toxicol 30:194-203 (1996).
20. Murk AJ, Legler J, Denison MS, Giesy JP, Van de Guchte C, Brouwer A. Chemical-activated luciferase gene expression (CALUX): a novel in vitro bioassay for Ah receptor active compounds in sediments and pore water. Fundam Appl Toxicol 33:149-160 (1996).
21. Meerts IATM, Luijks EAC, Marsh G, Jakobsson E, Bergman Å, Brouwer A. Polybrominated diphenyl ethers (PBDEs) as Ah-receptor agonists and antagonists. Organohalogen Compounds 37:147-150 (1998).
22. Sanderson JT, Aarts JMMJG, Brouwer A, Froese KL, Denison MS, Giesy JP. Comparison of Ah receptor-mediated luciferase and ethoxyresorufin-O-deethylase induction in H4IIE cells: implications for their use as bioanalytical tools for the detection of polyhalogenated aromatic hydrocarbons. Toxicol Appl Pharmacol 137:316-325 (1996).
23. Örn U, Klasson-Wehler E. Metabolism of 2,2′,4,4′-tetrabromodiphenyl ether in rat and mouse. Xenobiotica 28:199-211 (1998).
24. Asplund L, Athanasiadou M, Sjödin A, Bergman Å, Börjeson H. Organohalogen substances in muscle, egg, and blood from healthy Baltic salmon (Salmo salar) and Baltic salmon that produced offspring with the M74 syndrome. Ambio 28:67-76 (1999).
25. Marsh G, Bergman Å, Bladh L-G, Gillner M, Jakobsscn E. Synthesis of p-hydroxybromodiphenyl ethers and binding to the thyroid receptor. Organohalogen Compounds 37:305-308 (1998).
26. Zava DT, Bien M, Duwe G. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ Health Perspect 105(suppl 3):637-645 (1997).
27. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect 103:582-587 (1995).
28. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Olea-Serrano F. The E-SCREEN as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect 103(suppl 7):113-122 (1995).
29. Colborn T, vom Saal FS, Soto AM. Developmental effects of endocrine-disrupting chemcials in wildlife and humans. Environ Health Perspect 101:378-384 (1993).
30. Navas JM, Segner H. Antiestrogenic activity of anthropogenic and natural chemicals. Environ Sci Pollut Res 5:75-82 (1998).
31. Legler J, Van den Brink CE, Brouwer A, Murk AJ, Van der Saag PT, Vethaak AD, Van der Burg B. Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci 48:55-66 (1999).
32. Seinen W, Lemmen JG, Pieters RHH, Verbruggen EML, Van der Burg B. AHTN and HHCB show weak estrogenic - but no uterotrophic activity.Toxicol Lett 111:161-168 (1999).
33. Lemmen J. Unpublished data.
34. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson J-Å. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252-4263 (1998).
35. Marsh G, Hu J, Jakobsson E, Rahm S, Bergman Å. Synthesis and characterization of 32 polybrominated diphenyl ethers. Environ Sci Technol 33(17):3033-3037 (1999).
36. Örn U, Eriksson L, Jakobsson E, Bergman Å. Synthesis and characterization of polybrominated diphenyl ethers - unlabelled and radiolabelled tetra-, penta-and hexa-bromodiphenyl ethers. Acta Chem Scand 50:802-807 (1996).
37. Ballschmiter K, Mennel A, Buyten J. Long chain alkylpolysiloxanes as non-polar stationary phases in capillary gas chromatography. Fres J Anal Chem 346(4):396-402 (1993).
38. Horwitz KB, McGuire WL. Estrogen control of progesterone receptor in human breast cancer: correlation with nuclear processing of estrogen receptor. J Biol Chem 253:2222-2228 (1978).
39. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271-277 (1986).
40. Korach KS, Sarver P, Chae K, McLachlan JA, McKinney JD. Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: comformationally restricted structural probes. Mol Pharmacol 33:120-126 (1988).
41. Connor K, Ramamoorthy K, Moore M, Mustain M, Chen I, Safe S, Zacharewski T, Gillesby B, Joyeux A, Balaguer P. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Toxicol Appl Pharmacol 145:111-123 (1997).
42. Kuil CW, Brouwer A, Van der Saag PT, Van der Burg B. Interference between progesterone and dioxin signal transduction pathways: different mechanisms are involved in repression by the progesterone receptor A and B isoforms. J Biol Chem 273:8829-8834 (1998)
43. Spink DC, Spink BC, Cao JQ, Depasquale JA, Pentecost BT, Fasco MJ, Li Y, Sutter TR. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19:291-298 (1998).
44. Piao Y-S, Pelttoketo H, Jouppila A, Vihko R. Retinoid acids increase 17β-hydroxysteroid dehydrogenase type 1 expression in JEG-3 and T47D cells, but the stimulation is potentiated by epidermal growth factor, 12-0-tetradecanoylphorbol-13-acetate and cyclic adenosine 3′,5′-monophosphate only in JEG-3 cells. Endocrinology 138:898-904 (1997).
45. Larsen GL, Hakk H, Klasson-Wehler E, Örn U, Bergman Å. Binding of 2,2′,4,4′,5-pentabromodiphenyl ether (BDE-99) and/or its metabolites to mammalian urinary and biliary carrier proteins. Organohatogen Compounds 40:371-374 (1999).
46. Panno ML, Sisci D, Salerno M, Lanzino M. Mauro L, Morrone EG, Pezzi V, Palmero S, Fugassa E, Andó S. Effect of triiodothyronine administration on estrogen receptor contents in peripubertal Sertoli cells. Eur J Endocrinol 134:633-638 (1996).
47. Dellovade TL, Zhu Y-H, Krey L, Pfaff DW Thyroid hormone and estrogen interact to regulate behavior, Proc Natl Acad Sci USA 93:12581-12586 (1996).
48. Moore M, Mustain M. Daniel K, Chen I, Safe S, Zacharewski T, Gillesby B, Joyeux A, Balaguer P. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum. Toxicol Appl Pharmacol 142:160-168 (1997).
49. Brotons JA, Olea-Serrano MF, Villalobos M, Pedraza V, Olea N. Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 103:608-612 (1995).
50. Feldman D, Krishnan A. Estrogens in unexpected places: possible implications for researchers and consumers. Environ Health Perspect 103(suppl 7):129-133(1995).
51. Perez P, Pulgar R, Olea-Serrano F, Villalobos M, Rivas A, Metzler M, Pedraza V, Olea N. The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups. Environ Health Perspect 106:167-174 (1998).
52. Safe S, Wang F, Porter W, Duan R. McDougal A. Ah receptor agonists as endocrine disrupters: antiestrogenic activity and mechanisms. Toxicol Lett 102-103:343-347 (1998).
53. Krishnan V, Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs) as antiesuogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships. Toxicol Appl Pharmacol 120:55-61 (1993).
54. Spink DC, Lincoln DW, Dickerman HW, Gierthy JF. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes extensive alteration of 17β-estradiol metabolism in MCF-7 breast tumour cells. Proc Natl Acad Sci 87:6917-6921 (1990).
55. Zacharewski T, Bondy KL, McDonell P, Wu ZF. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression. Cancer Res 54:2707-2713 (1994).
56. McKinney JD, Waller CL. Polychlorinated biphenyls as hormonally active structural analogues. Environ Health Perspect 102:290-297 (1994).
57. Routledge EJ, Sumpter JP. Estrogenic activity of surfactants and some of their degradation products assessed using a recombinant yeast screen. Environ Toxicol Chem 272:3280-3288 (1996).